Assetmark »

SPDR S&P Pharmaceuticals shares owned by Assetmark

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by Assetmark from 13F filings

Historical chart of Assetmark investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by Assetmark consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by Assetmark

Quarter filed Position value Share count Share price at filing
2026-06-30 $8.3k 125 66.27
2016-12-31 $3.0k 73 41.10

More positions owned by Assetmark

Vanguard World Mega Grwth Ind (MGK)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard World Mega Cap Val Etf (MGV)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Apple (AAPL)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Ishares Core Msci Emkt (IEMG)
Microsoft Corporation (MSFT)
Vanguard Index Fds Mcap Gr Idxvip (VOT)
Ishares Tr Us Treas Bd Etf (GOVT)
Spdr Series Trust St Bloo High Etf (JNK)

View all positions for Assetmark

Top funds holding SPDR S&P Pharmaceuticals

Bank of America Corporation
CWM
Wells Fargo & Company
Kingsview Wealth Management
Morgan Stanley
Envestnet Asset Management
First Citizens Bank & Trust
Envestnet Portfolio Solutions
LPL Financial
Susquehanna International
Branch Banking & Trust Company
Cetera Investment Advisers
Private Advisor
Two Sigma Investments
Citigroup

View all funds holding SPDR S&P Pharmaceuticals